An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Name: An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
Published: 2021
License: Public Domain

Xiamen University · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

cervical-cancer immunogenicity

cervical cancer, condylomata acuminata, human papillomavirus vaccine, immunogenicity, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Related documents